Annual report pursuant to Section 13 and 15(d)

EARNINGS PER SHARE (Tables)

v3.20.4
EARNINGS PER SHARE (Tables)
12 Months Ended
Nov. 30, 2020
Earnings Per Share [Abstract]  
Schedule of anti-dilutive shares

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

    November 30,  
    2020     2019  
Series A Preferred Stock     46,366,490        
Warrants     5,857,386       45,787,219  
Stock Options     7,059,667       2,911,667  
Restricted Stock     15,735,000        
Total     75,018,543       48,698,886